Serina Therapeutics SER
NYSE SER
$2.43 -0.14 (-5.36%)
As of: Sep 10, 2026 · 3:59 PM EDT

Serina Therapeutics (SER) Tax Rate (2019)

Serina Therapeutics' (SER) quarterly Tax Rate came in at 0.66% in Q4 2019, up 60.55% quarter-over-quarter from 1.68% in Q3 2019.

Analysis

Serina Therapeutics (SER) Tax Rate (2019) Analysis & Trends

Serina Therapeutics has disclosed Tax Rate across 1 years of filings, most recently posting 0.66% for Q4 2019.

  • In Q4 2019, Tax Rate changed N/A year-over-year to 0.66%; the TTM figure through Dec 2019 stood at 1.21% (changed N/A YoY), while the FY2025 annual figure was 0.09%, changed N/A from the prior year.
  • Tax Rate came in at 0.66% for Q4 2019 at Serina Therapeutics, up from 1.68% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 0.1% in Q2 2019 to a low of 2.33% in Q1 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 14.20%
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -2.36%
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 20.98%
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 15.11%
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -10.89%
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -1.96%
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 7.49%
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 26.36%
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 1.34%
10 Serina Therapeutics 40.47 Mn 17.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -0.66%
Sep 30, 2019 -1.68%
Jun 30, 2019 -0.10%
Mar 31, 2019 -2.33%